Analysis of potentially inappropriate medications in elderly inpatients based on Beers Criteria and Chinese Criteria
WAN Miaomiao
WANG Jianchun
ZHANG Feng
ZHANG Wen
ZHU Xiaojuan
Abstract:Objective To analyze potentially inappropriate medication(PIM)in elderly inpatients using the 2019 Beers Criteria and the Chinese Criteria of Potentially Inappropriate Medication for Older Adults(2017 edition)(Chinese Criteria).Methods A total of 191 inpatients aged≥65 years admitted to the Department of Geriatrics of Shandong Pro-vincial Hospital Affiliated to Shandong First Medical University from January to June 2020 were selected.PIM analysis was performed based on the 2019 Beers Criteria and Chinese Criteria.The χ2 test was used to compare the incidence rates of PIM by two criteria across different indicators(age,sex,number of diseases,number of medications,renal function).Results According to the Beers Criteria and Chinese Criteria,the incidence rates of PIM were 72.25%(138/191)and 60.73%(116/191),respectively.The most frequent PIM were proton pump inhibitors(based on Beers Criteria)and clopidogrel(based on Chinese Criteria).Difference of PIM incidence was found according to both Beers Criteria and Chi-nese Criteria among elderly inpatients taking 1-4,5-9,and≥10 medications(all P<0.05).According to the Chinese Cri-teria,difference in PIM incidence was observed between patients with normal and abnormal renal function(P<0.05).Conclusions Based on the 2019 Beers Criteria and Chinese Criteria,the incidence of PIM among elderly inpatients is very high.Elderly patients taking more medications and those with abnormal renal function are more prone to PIM.
Keywords:potentially inappropriate medicationpolypharmacyrenal functionBeers criteriaChinese Criteria of Potentially Inappropriate Medication for Older Adults
Publication Date:2025-08-25
Online Publishing Date:2025-09-17(First online date of this platform, not the publication date of the document)
Pages:4( 1-4 )
Geriatrics Research

Geriatrics Research

ISSN:2096-9058
Year, Vol.(Issue):2025,6(4)